Fulgent Genetics Executive Sells Shares Amid Financial Reporting and Pipeline Updates
Fulgent Genetics' COO, Jian Xie, sold a block of common shares to cover tax withholding related to vested restricted units. While the company recently reported first-quarter financial results that fell short of analyst expectations, management continues to detail several key initiatives, including a new pharmacogenetic testing service with Foundati…